Filter Results :

Your search for Hematological returned 14 reports

Sort by


Other Hematological Disorders-Pipeline Insights, 2016

03 Nov 2016  |  Published by:  DelveInsight
SUMMARY'Other Hematological Disorders-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Other Hematological Disorders. This report p...

$ 1,250.00
$ 750.00
( Save 40% )

Read More

Global Hematological Cancers Market Research Report 2016

18 Jul 2016  |  Published by:  9Dimen Research
2016 Global Advanced Distributed Management System (ADMS) Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Advanced Distributed Management System (ADMS) industry, focusing on the main regions (North America, Europe and Asia) and th...

$ 2,850.00

Read More

Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies

01 Jun 2016  |  Published by:  GBI Research
Summary Hematological malignancies are a class of cancer that affect the blood, lymph nodes and bone marrow, and include numerous forms of leukemia, lymphoma and myeloma. Hematological malignancies constituted 9% of all newly diagnosed malignancies in the US in 2011, with data indicating th...

$ 6,995.00

Read More

Global Hematological Cancers Market to 2022 - Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market

21 Apr 2016  |  Published by:  GBI Research
SummaryHematological malignancies are a class of cancer that affect the blood, lymph nodes and bone marrow. They include numerous forms of leukemia, lymphoma and myeloma. Hematological malignancies constituted 9% of all newly diagnosed malignancies in the US in 2011, with data indica...

$ 4,995.00

Read More

Global Non-Hematological Cancers Market to 2021 - Strong growth driven by increased uptake of low toxicity targeted treatments and versatile biologics

01 Apr 2016  |  Published by:  GBI Research
SummaryIn 2012, there were 32.6 million people living with any type of cancer within five years of diagnosis, non-hematological cancers are thought to account for 94% of global cancer prevalence. The key cancer indications of this report, namely breast, colorectal, lung and prostate ...

$ 4,995.00

Read More

Gene Therapy Hematological Disorders Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

01 Jan 2016  |  Published by:  DelveInsight
Summary Gene Therapy Hematological Disorders Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and...

$ 3,000.00

Read More

Hematological Tumor Global Clinical Trials Review, H1, 2015

16 Mar 2015  |  Published by:  GlobalData
Summary“Hematological Tumor Global Clinical Trials Review, H1, 2015" provides data on the Hematological Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hematological Tumor. It includes an overview of the trial numbers and their re...

$ 2,500.00
$ 2,125.00
( Save 15% )

Read More

Hematological Malignancies: Multiple Myeloma (MM) - Early and Robust Diagnosis along with New Treatment Options can have Considerable Impact on Management of the Disease

21 Jan 2015  |  Published by:  MP Advisors
While targeting unmet needs in the treatment of hematological malignancies/ cancer through innovative drug development strategies have witnessed favorable outcomes, the specific choice of the therapies is dependent on the identification of important genomic alterations in cancerous cells that ...

$ 3,000.00
$ 2,550.00
( Save 15% )

Read More

Hematological Tumor - Pipeline Review, H1 2014

30 Jun 2014  |  Published by:  Global Markets Direct
Summary‘Hematological Tumor - Pipeline Review, H1 2014’, provides an overview of the Hematological Tumor’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hematological Tumor, complete with comparative analysis at various stages, therapeutics as...

$ 2,000.00
$ 1,600.00
( Save 20% )

Read More

Treating Refractory Hematological Malignancies

22 Feb 2014  |  Published by:  MP Advisors
Targeting unmet needs in the treatment of cancer/ hematological malignancies through innovative drug development strategies have witnessed favorable outcomes. Over the past decade, Proteasome inhibitor, Velcade (bortezomib) and the immunomodulatory drugs – Thalomid (thalidomide) and Revlimid (...

$ 2,500.00
$ 2,125.00
( Save 15% )

Read More

Treating Refractory Hematological Malignancies - Multiple Myeloma (MM): New Treatment Options Driving In-Licensing and M&A

13 Sep 2013  |  Published by:  MP Advisors
The report provides an overview of the therapies for Multiple Myeloma (Newly diagnosed - NDMM and relapsed/ refractory - RRMM), unmet need, and limitations of the current standard of care (SoC) for relapsed and refractory MM pts. The report highlights the competition and commercial opportunity...

$ 2,500.00
$ 2,125.00
( Save 15% )

Read More

Treating Refractory Hematological Malignancies - Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML): Emerging Therapeutics

29 Aug 2013  |  Published by:  MP Advisors
The report provides an overview of the approved therapies for AML, MDS, unmet need and limitations of the current SOC for relapsed and refractory pts. The report highlights the competition and commercial opportunity in pursuing this therapy area – Comprehensive list of the early and late stage...

$ 2,500.00
$ 2,125.00
( Save 15% )

Read More

Drugs and Diagnostics for Hematological Disorders: Global Markets

06 Mar 2013  |  Published by:  BCC Research-JT Gabrielsen Consulting LLC Research
REPORT HIGHLIGHTS This report provides: -An overview of the global market for drugs and diagnostics for hematological disorders.-Analyses of global market trends, with data from 2010 through 2012, and projections of compound annual growth rates (CAGRs) through 2017.-A breakdown of the market...

$ 6,650.00

Read More

Apheresis Equipment Market (Plasmapheresis, Photopheresis, Apheresis In Neurological, Renal, Hematological Diseases, Centrifugation, Membrane Filtration, Apheresis Machines And Disposable Kits)

27 Feb 2013  |  Published by:  Transparency Market Research
Apheresis Equipment Market (Plasmapheresis, Photopheresis, Apheresis In Neurological, Renal, Hematological Diseases, Centrifugation, Membrane Filtration, Apheresis Machines And Disposable Kits) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018This report on the global...

$ 4,595.00

Read More
Total 14 records.